论文部分内容阅读
澳大利亚和瑞士的科学家证明胰升糖素样肽(GLP-1)类似物Byetta(exenatide)对于帕-魏二氏综合征(Prader-Willi syndrome,PWS)患者安全、有效且耐受性良好。PWS是一种由暴食和肥胖引起的遗传病。
Scientists in Australia and Switzerland have shown that Byetta (exenatide), an analog of the glucagon-like peptide (GLP-1), is safe, effective and well tolerated in patients with Prader-Willi syndrome (PWS). PWS is a genetic disease caused by binge eating and obesity.